187 related articles for article (PubMed ID: 24667764)
1. Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.
Koyama N; Nishida Y; Ishii T; Yoshida T; Furukawa Y; Narahara H
PLoS One; 2014; 9(3):e93050. PubMed ID: 24667764
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan is a potent target for prevention and treatment in human prostate cancer.
Funao K; Matsuyama M; Kawahito Y; Sano H; Chargui J; Touraine JL; Nakatani T; Yoshimura R
Oncol Rep; 2008 Aug; 20(2):295-300. PubMed ID: 18636189
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.
Li J; Chen L; Yu P; Liu B; Zhu J; Yang Y
Molecules; 2014 Mar; 19(3):2862-76. PubMed ID: 24603556
[TBL] [Abstract][Full Text] [Related]
6. Increase of human prostate cancer cell (DU145) apoptosis by telmisartan through PPAR-delta pathway.
Wu TT; Niu HS; Chen LJ; Cheng JT; Tong YC
Eur J Pharmacol; 2016 Mar; 775():35-42. PubMed ID: 26852954
[TBL] [Abstract][Full Text] [Related]
7. Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.
Konecny GE; Kolarova T; O'Brien NA; Winterhoff B; Yang G; Qi J; Qi Z; Venkatesan N; Ayala R; Luo T; Finn RS; Kristof J; Galderisi C; Porta DG; Anderson L; Shi MM; Yovine A; Slamon DJ
Mol Cancer Ther; 2013 May; 12(5):632-42. PubMed ID: 23443805
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan prevents proliferation and promotes apoptosis of human ovarian cancer cells through upregulating PPARγ and downregulating MMP‑9 expression.
Pu Z; Zhu M; Kong F
Mol Med Rep; 2016 Jan; 13(1):555-9. PubMed ID: 26548340
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
Matsumura T; Kinoshita H; Ishii N; Fukuda K; Motoshima H; Senokuchi T; Taketa K; Kawasaki S; Nishimaki-Mogami T; Kawada T; Nishikawa T; Araki E
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1268-75. PubMed ID: 21474824
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.
Siragusa M; Sessa WC
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1852-60. PubMed ID: 23702662
[TBL] [Abstract][Full Text] [Related]
14. High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.
Bähr IN; Tretter P; Krüger J; Stark RG; Schimkus J; Unger T; Kappert K; Scholze J; Parhofer KG; Kintscher U
Hypertension; 2011 Oct; 58(4):725-32. PubMed ID: 21876071
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan modulates mitochondrial function in vascular smooth muscle cells.
Takeuchi K; Yamamoto K; Ohishi M; Takeshita H; Hongyo K; Kawai T; Takeda M; Kamide K; Kurtz TW; Rakugi H
Hypertens Res; 2013 May; 36(5):433-9. PubMed ID: 23254392
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Ishii T; Kira N; Yoshida T; Narahara H
Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Δ(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines.
Li H; Narahara H
Int J Mol Med; 2013 Apr; 31(4):778-88. PubMed ID: 23403520
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.
Wang J; Pang T; Hafko R; Benicky J; Sanchez-Lemus E; Saavedra JM
Neuropharmacology; 2014 Apr; 79():249-61. PubMed ID: 24316465
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
